Absolute	absolute	O	O	O	O
and	and	O	O	O	O
attributable	attributable	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
venous	venous	O	DISEASE	OTHERS	I
thromboembolism	thromboembolism	O	DISEASE	OTHERS	I
in	in	O	O	O	O
women	women	O	O	O	O
on	on	O	O	O	O
combined	combined	O	O	O	O
cyproterone	cyproterone	CHEMICALS	O	OTHERS	I
acetate	acetate	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
ethinylestradiol	ethinylestradiol	O	O	OTHERS	I
.	.	O	O	O	O

OBJECTIVE	objective	O	O	O	O
:	:	O	O	O	O
To	to	O	O	O	O
achieve	achieve	O	O	O	O
absolute	absolute	O	O	O	O
risk	risk	O	O	O	O
estimates	estimates	O	O	O	O
of	of	O	O	O	O
venous	venous	O	DISEASE	OTHERS	I
thromboembolism	thromboembolism	O	DISEASE	OTHERS	I
(	(	O	O	O	O
VTE	vte	O	DISEASE	OTHERS	I
)	)	O	O	O	O
among	among	O	O	O	O
women	women	O	O	O	O
on	on	O	O	O	O
cyproterone	cyproterone	CHEMICALS	O	OTHERS	I
acetate	acetate	CHEMICALS	O	OTHERS	I
plus	plus	O	O	O	O
ethinylestradiol	ethinylestradiol	O	O	OTHERS	I
(	(	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
among	among	O	O	O	O
women	women	O	O	O	O
on	on	O	O	O	O
combined	combined	O	O	OTHERS	I
oral	oral	CHEMICALS	O	OTHERS	I
contraceptives	contraceptives	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
COCs	cocs	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
From	from	O	O	O	O
the	the	O	O	O	O
Danish	danish	O	O	O	O
National	national	O	O	O	O
Register	register	O	O	O	O
of	of	O	O	O	O
Patients	patients	O	O	O	O
(	(	O	O	O	O
NRP	nrp	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
1996	1996	O	O	O	O
to	to	O	O	O	O
1998	1998	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
records	records	O	O	O	O
of	of	O	O	O	O
1.1	1.1	O	O	O	O
million	million	O	O	O	O
Danish	danish	O	O	O	O
women	women	O	O	O	O
,	,	O	O	O	O
ages	ages	O	O	O	O
15	15	O	O	O	O
to	to	O	O	O	O
44	44	O	O	O	O
years	years	O	O	O	O
,	,	O	O	O	O
were	were	O	O	O	O
searched	searched	O	O	O	O
for	for	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
VTE	vte	O	DISEASE	OTHERS	I
.	.	O	O	O	O

COC	coc	O	O	OTHERS	I
use	use	O	O	O	O
was	was	O	O	O	O
ascertained	ascertained	O	O	O	O
through	through	O	O	O	O
mailed	mailed	O	O	O	O
questionnaires	questionnaires	O	O	O	O
.	.	O	O	O	O

Sales	sales	O	O	O	O
statistics	statistics	O	O	O	O
of	of	O	O	O	O
COCs	cocs	O	O	OTHERS	I
and	and	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
were	were	O	O	O	O
provided	provided	O	O	O	O
through	through	O	O	O	O
Danish	danish	O	O	O	O
Drug	drug	O	O	O	O
Statistics	statistics	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
During	during	O	O	O	O
the	the	O	O	O	O
time	time	O	O	O	O
frame	frame	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
330	330	O	O	O	O
women	women	O	O	O	O
were	were	O	O	O	O
found	found	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
had	had	O	O	O	O
VTE	vte	O	DISEASE	OTHERS	I
while	while	O	O	O	O
on	on	O	O	O	O
COCs	cocs	O	O	OTHERS	I
.	.	O	O	O	O

Of	of	O	O	O	O
these	these	O	O	O	O
women	women	O	O	O	O
,	,	O	O	O	O
67	67	O	O	O	O
were	were	O	O	O	O
on	on	O	O	O	O
levonorgestrel-containing	levonorgestrel-containing	O	O	O	O
COCs	cocs	O	O	OTHERS	I
.	.	O	O	O	O

Eleven	eleven	O	O	O	O
were	were	O	O	O	O
on	on	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
corresponding	corresponding	O	O	O	O
absolute	absolute	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
VTE	vte	O	DISEASE	OTHERS	I
was	was	O	O	O	O
3.4	3.4	O	O	O	O
(	(	O	O	O	O
range	range	O	O	O	O
,	,	O	O	O	O
3.1	3.1	O	O	O	O
-	-	O	O	O	O
3.8	3.8	O	O	O	O
)	)	O	O	O	O
per	per	O	O	O	O
10	10	O	O	O	O
000	000	O	O	O	O
women	women	O	O	O	O
years	years	O	O	O	O
among	among	O	O	O	O
the	the	O	O	O	O
women	women	O	O	O	O
on	on	O	O	O	O
COCs	cocs	O	O	OTHERS	I
,	,	O	O	O	O
4.2	4.2	O	O	O	O
(	(	O	O	O	O
range	range	O	O	O	O
,	,	O	O	O	O
3.2	3.2	O	O	O	O
-	-	O	O	O	O
5.2	5.2	O	O	O	O
)	)	O	O	O	O
per	per	O	O	O	O
10	10	O	O	O	O
000	000	O	O	O	O
women	women	O	O	O	O
years	years	O	O	O	O
among	among	O	O	O	O
women	women	O	O	O	O
on	on	O	O	O	O
levonorgestrel-containing	levonorgestrel-containing	O	O	O	O
COCs	cocs	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
3.1	3.1	O	O	O	O
(	(	O	O	O	O
range	range	O	O	O	O
,	,	O	O	O	O
1.3	1.3	O	O	O	O
-	-	O	O	O	O
4.9	4.9	O	O	O	O
)	)	O	O	O	O
per	per	O	O	O	O
10	10	O	O	O	O
000	000	O	O	O	O
women	women	O	O	O	O
years	years	O	O	O	O
among	among	O	O	O	O
the	the	O	O	O	O
women	women	O	O	O	O
on	on	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
.	.	O	O	O	O

CONCLUSION	conclusion	O	O	O	O
:	:	O	O	O	O
Our	our	O	O	O	O
results	results	O	O	O	O
suggest	suggest	O	O	O	O
the	the	O	O	O	O
absolute	absolute	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
VTE	vte	O	DISEASE	OTHERS	I
among	among	O	O	O	O
Danish	danish	O	O	O	O
women	women	O	O	O	O
on	on	O	O	O	O
COCs	cocs	O	O	OTHERS	I
is	is	O	O	O	O
similar	similar	O	O	O	O
to	to	O	O	O	O
that	that	O	O	O	O
among	among	O	O	O	O
women	women	O	O	O	O
taking	taking	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
.	.	O	O	O	O

